LEUCHTENBERGER MARK enters NEUROSENSE THERAPEUTICS LTD. with 325.95K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001213900-26-030598
Director
Since Mar 2026
325.95K
Baseline shares
100% direct
325.95K
Direct ownership
3 positions
192K
Derivative underlying
1 instrument
3
Security positions
All direct
Non-Derivative Holdings3
Ordinary Shares
DirectShares owned75K
Ordinary Shares
DirectShares owned128K
Ordinary Shares
DirectShares owned122.95K
Total
325.95K direct325.95K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 75K | Direct |
| Ordinary Shares | 128K | Direct |
| Ordinary Shares | 122.95K | Direct |
| Total | 325.95K | 325.95K direct |
Derivative Holdings1
Options to Purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
192K
Shares owned
N/A
Exercise price
3.51
Expiration
—
Exercise window
—
Total
Underlying
192K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 3.51 | — | — | 192K | N/A |
| Total | 192K | 0.00 | ||||